Theranica announced today that it has signed a contract to supply its Nerivio device to the U.S. Department of Veterans Affairs (VA) for use by veterans who suffer from chronic migraine headaches. Nerivio is worn on the upper arm for 45 minutes and uses remote electrical neuromodulation to activate the brain’s native conditioned pain modulation […]
Theranica Bio-Electronics
FDA clears Theranica device for adolescent migraines
Theranica announced today that the FDA has granted expanded clearance for the use of its Nerivio acute migraine treatment device by people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. According to the study, 28 of 39 (71%) of the adolescent participants using […]
Ambu, Boston Sci execs see domination for single-use scopes
Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost. In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S and Boston Scientific (NYSE:BSX) said improved technology make […]
The top 5 MassDevice stories of the week — September 11, 2020
From the Theranos case to wearable medical devices, it’s been another busy news week for the medical device industry. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five: […]
Theranica lands CE mark for migraine device
Theranica announced today that it received CE Mark approval for its Nerivio device for the acute treatment of migraine. Montclair, N.J.-based Theranica adds European approval just over a year since it received FDA de novo clearance for the neurostimulation device in May 2019. The approval allows for the company to begin marketing the device in […]
Theranica wins de novo FDA clearance for migraine armband
Theranica said today that it won FDA de novo clearance for its Nerivio Migra remote electrical neuromodulation system intended for the acute treatment of migraines. The approval came based off a prospective, randomized, double-blind, placebo-controlled, multi-center pivotal study of 252 patients, the Israel-based company said. Data from the study was published in Headache: The Journal of […]
Omron joins $35m Theranica Series B
Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]
Theranica raises $35m Series B for neuromod migraine patch
Theranica Bio-Electronics said yesterday that it raised a $35 million Series B round for the Nerivio Migra neurostim patch it’s developing to treat migraine headache. Netanya, Israel-based Theranica said VC shop aMoon led the round, joined by all of its existing backers, Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa. The company raised an […]
Theranica raises seed round for Nerivio Migra wearable migraine device
Newly-formed med device company Theranica Bio-Electronics said today it closed a seed financing round led by Dr. Shimon Eckhouse and joined by a group of angel investors. The company did not release the amount raised in the round. Israel-based Theranica is developing the Nerivio Migra, a disposable neuromodulation patch designed to treat migraine headaches. “Theranica […]